| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Treatment with monoclonal antibodies against Clostridium difficile toxins.
|
N Engl J Med
|
2010
|
7.37
|
|
2
|
Waning protection after fifth dose of acellular pertussis vaccine in children.
|
N Engl J Med
|
2012
|
3.12
|
|
3
|
Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children.
|
JAMA Pediatr
|
2013
|
2.86
|
|
4
|
Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures.
|
Pediatrics
|
2010
|
2.39
|
|
5
|
Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.
|
Vaccine
|
2010
|
1.99
|
|
6
|
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.
|
Pediatr Infect Dis J
|
2004
|
1.90
|
|
7
|
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).
|
Vaccine
|
2009
|
1.85
|
|
8
|
Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.
|
Blood
|
2012
|
1.68
|
|
9
|
The Vaccine Safety Datalink: a model for monitoring immunization safety.
|
Pediatrics
|
2011
|
1.60
|
|
10
|
Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies.
|
Vaccine
|
2009
|
1.50
|
|
11
|
Immunization and Bell's palsy in children: a case-centered analysis.
|
Am J Epidemiol
|
2012
|
1.47
|
|
12
|
Influenza vaccination and mortality: differentiating vaccine effects from bias.
|
Am J Epidemiol
|
2009
|
1.46
|
|
13
|
Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers.
|
Pediatrics
|
2013
|
1.39
|
|
14
|
Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study.
|
BMC Infect Dis
|
2013
|
1.32
|
|
15
|
Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.
|
Am J Epidemiol
|
2012
|
1.20
|
|
16
|
Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization.
|
J Clin Microbiol
|
2012
|
1.20
|
|
17
|
Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
|
Clin Infect Dis
|
2009
|
1.18
|
|
18
|
Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra.
|
Clin Vaccine Immunol
|
2009
|
1.13
|
|
19
|
H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.
|
Am J Prev Med
|
2011
|
1.12
|
|
20
|
The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy.
|
Pharmacoepidemiol Drug Saf
|
2010
|
1.11
|
|
21
|
Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents.
|
Hum Vaccin
|
2010
|
1.09
|
|
22
|
Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults.
|
Vaccine
|
2006
|
1.04
|
|
23
|
Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.
|
Am J Epidemiol
|
2009
|
1.04
|
|
24
|
An observational cohort study of Chlamydia trachomatis treatment in pregnancy.
|
Sex Transm Dis
|
2006
|
1.01
|
|
25
|
Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa.
|
Clin Infect Dis
|
2005
|
0.99
|
|
26
|
Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.
|
PLoS One
|
2013
|
0.99
|
|
27
|
Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus.
|
Diagn Microbiol Infect Dis
|
2013
|
0.98
|
|
28
|
A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age.
|
Vaccine
|
2013
|
0.96
|
|
29
|
Measles-containing vaccines and febrile seizures in children age 4 to 6 years.
|
Pediatrics
|
2012
|
0.96
|
|
30
|
Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010.
|
Influenza Other Respir Viruses
|
2012
|
0.96
|
|
31
|
Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
|
Vaccine
|
2012
|
0.93
|
|
32
|
Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic.
|
Am J Epidemiol
|
2013
|
0.93
|
|
33
|
Varicella vaccination and ischemic stroke in children: is there an association?
|
Pediatrics
|
2009
|
0.91
|
|
34
|
Biologically plausible and evidence-based risk intervals in immunization safety research.
|
Vaccine
|
2012
|
0.89
|
|
35
|
Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children.
|
Vaccine
|
2013
|
0.86
|
|
36
|
The risk of immune thrombocytopenic purpura after vaccination in children and adolescents.
|
Pediatrics
|
2012
|
0.86
|
|
37
|
Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.
|
Pharmacoepidemiol Drug Saf
|
2014
|
0.84
|
|
38
|
Air Pollution and Pulmonary Tuberculosis: A Nested Case-Control Study among Members of a Northern California Health Plan.
|
Environ Health Perspect
|
2016
|
0.83
|
|
39
|
Mortality rates and cause-of-death patterns in a vaccinated population.
|
Am J Prev Med
|
2013
|
0.82
|
|
40
|
Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study.
|
BMC Infect Dis
|
2009
|
0.82
|
|
41
|
Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study.
|
BMC Infect Dis
|
2009
|
0.82
|
|
42
|
Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.
|
Vaccine
|
2013
|
0.81
|
|
43
|
Diagnostic challenges of central nervous system tuberculosis.
|
Emerg Infect Dis
|
2008
|
0.80
|
|
44
|
Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population.
|
Clin Infect Dis
|
2012
|
0.79
|
|
45
|
Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
|
Pediatrics
|
2011
|
0.79
|
|
46
|
Evaluation of immunization rates and safety among children with inborn errors of metabolism.
|
Pediatrics
|
2011
|
0.79
|
|
47
|
Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study.
|
Vaccine
|
2009
|
0.78
|
|
48
|
Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact.
|
Cancer Causes Control
|
2013
|
0.78
|
|
49
|
Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age.
|
Vaccine
|
2011
|
0.77
|
|
50
|
Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza.
|
Vaccine
|
2011
|
0.77
|
|
51
|
Injection site and risk of medically attended local reactions to acellular pertussis vaccine.
|
Pediatrics
|
2011
|
0.77
|
|
52
|
Live vaccine use and safety in DiGeorge syndrome.
|
Pediatrics
|
2014
|
0.77
|
|
53
|
Epidemiologic and clinical features of Bell's palsy among children in Northern California.
|
Neuroepidemiology
|
2012
|
0.77
|
|
54
|
Developing the next generation of vaccinologists.
|
Vaccine
|
2011
|
0.75
|
|
55
|
Infective endocarditis.
|
N Engl J Med
|
2002
|
0.75
|
|
56
|
Algorithm to assess causality after individual adverse events following immunizations.
|
Vaccine
|
2012
|
0.75
|
|
57
|
Cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ: comparison of ICD-9 codes and pathology results--Kaiser Permanente, United States, 2000-2005.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.75
|
|
58
|
Vaccination site and risk of local reactions in children 1 through 6 years of age.
|
Pediatrics
|
2013
|
0.75
|
|
59
|
Immunogenicity and safety of MMRV and PCV-7 administered concomitantly in healthy children.
|
Pediatrics
|
2011
|
0.75
|
|
60
|
Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010.
|
Pharmacoepidemiol Drug Saf
|
2012
|
0.75
|
|
61
|
Assessing the safety of influenza vaccination in specific populations: children and the elderly.
|
Expert Rev Vaccines
|
2012
|
0.75
|